Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
March 4, 2024Future Medicinal ChemistryOpen Access

Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMona S. El‐ZoghbiABAmr K. A. BassGAGamal El‐Din A. Abuo‐Rahma

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

El‐Zoghbi et al. (2024) studied this question.

synapsesocial.com/papers/68e75c84b6db6435876d32c1https://doi.org/10.4155/fmc-2023-0336
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase II trial of panobinostat, an oral pan‐deacetylase inhibitor in patients with primary myelofibrosis, post–essential thrombocythaemia, and post–polycythaemia vera myelofibrosis2013 · 72 citations
  2. 2Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase Inhibitors2012 · 29 citations
  3. 3Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms2014 · 26 citations